Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease

The recommended treatment regimen for Mycobacterium avium complex pulmonary disease (MAC-PD) consists of three drugs: rifampicin, ethambutol, and azithromycin. IV amikacin can be added in the initial 2 to 3 months for patients with severe or recurrent disease.1Daley C.L. Iaccarino J.M. Lange C. et al.Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J. 2020; 56:...